Acción 300434 SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Sichuan Goldstone Asia Pharmaceutical Inc.

Acciones

300434

CNE100001YX5

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 26/06/2024 		Varia. Cinco días. Varia. 1 de enero.
7,76 CNY +2,37 % Gráfico intradía de Sichuan Goldstone Asia Pharmaceutical Inc. -2,27 % -29,84 %
27/05 Sichuan Goldstone Asia Pharmaceutical Inc. Aprueba el Dividendo en Efectivo para 2023 CI
26/04 Sichuan Goldstone Asia Pharmaceutical Inc. Propone Dividendo Final en Efectivo para 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Sichuan Goldstone Asia Pharmaceutical Inc.(XSEC:300434) dropped from S&P Global BMI Index
Sichuan Goldstone Asia Pharmaceutical Inc. Approves Cash Dividend on A Shares for 2023, Payable on 28 June 2024
Sichuan Goldstone Asia Pharmaceutical Inc. Proposes Final Cash Dividend for 2023
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Hangzhou Solipharma Technology Development Co., Ltd. announced that it expects to receive CNY 69.4857 million in funding from Sichuan Goldstone Asia Pharmaceutical Inc., Hangzhou Huolongguo Investment Management Co., Ltd. and another investor
Sichuan Goldstone Asia Pharmaceutical Inc. Approves Management Appointments
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Sichuan Goldstone Asia Pharmaceutical Inc.(XSEC:300434) added to S&P Global BMI Index
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021
Gao Yaping completed the acquisition of 5.1% shares of Sichuan Goldstone Asia Pharmaceutical Inc. from Kuai Yixi and Yang Xiaodong.
Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
Gao Yaping signed an equity transfer agreement to acquire 5.1% shares of Sichuan Goldstone Asia Pharmaceutical Inc. from Kuai Yixi and Yang Xiaodong for approximately CNY 170 million.
Sichuan Goldstone Orient New Material Equipment Co., Ltd. Approves Final Cash Dividend for the Year 2020
Sichuan Goldstone Asia Pharmaceutical Inc. signed Equity Acquisition agreement to acquire 65.40% stake in Zhejiang Jiande Zhengfa Pharmaceutical Co.Ltd from group of shareholders for approximately CNY 150 million
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 300434
  4. Noticias Sichuan Goldstone Asia Pharmaceutical Inc.
  5. Otros idiomas